-
Pre-Open Stock Movers 12/18: (ZAGG) (OVAS) (TTPH) (RAD) Higher; (MLHR) (KEX) (BRKR) Lower (more
-
Notable Analyst Rating Changes 11/25: (TJX) (PBR) (UTX) Upgraded; (P) (CYBR) (NFLX) Downgraded
-
Notable Analyst Rating Changes 9/22: (HOLX) (GSK) (MTZ) Upgraded; (OUTR) (YHOO) (INVN) Downgraded
-
Notable Mergers and Acquisitions of the Day 04/22: (GSK)/(NVS) (VRX)/(AGN) (CDNS)
-
Pre-Open Stock Movers 4/2: (MNKD) (ENVI) (XLRN) Higher; (AGEN) (LQDT) (AGU) Lower (more...)
-
Notable Mergers and Acquisitions of the Day 09/09: (MOLX) (WDC) (GSK) (JEC)
-
Pre-Open Movers 8/22: (SRZ) (KTCC) (WSM) Higher; (EXPR) (CLWR) (DELL) Lower (more...)
-
Human Genome (HGSI) Could Get 15% More in Takeover Bid - Analyst
-
Disappointing Trial Results on Albiglutide Make Glaxo Bid for Human Genome Less Likely -RBC (GSK) (HGSI)
-
Notable Analyst Rating Changes 05/31: (GS) (NVDA) (TZOO) Upgraded; (GSK) (MDT) (TASR) Downgraded
-
Daily State of the Markets 01/11: Bulls, Bears (and Cubbies)
-
Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
-
David Moenning's Daily State of the Markets: 3/18
-
Notable Analyst Rating Changes 1/26: LEN, GRMN, LUV, PETM, LEAP Upgraded; BHP, BAC, USB, AFL, ENR Downgraded
-
Unusual 11 Mid-Day Movers 4/16: POZN, SORC, EXM, GRO Higher; TLB, HCSG, GLG, CDL Lower
-
Notable Analyst Rating Changes 2/11: GSK, RTN, BIDU, VMW Upgraded; LVLT, AXP, MSFT, DRI Downgraded
-
David Moenning's Daily State of the Markets: 2/11